Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?
Alogliptin benz cost?
Combivent generic equivalent?
Patent expiry trametinib?
When is the expected fda decision date for apotex's ruxolitinib resubmission?

Evenity biosimilar?

See the DrugPatentWatch profile for Evenity

Evenity (darolutamide) – Quick Overview

Feature Details
Drug Class Small‑molecule androgen‑receptor antagonist
Manufacturer Pfizer (US) / Bayer (EU)
Indication Non‑metastatic castration‑resistant prostate cancer (nmCRPC) in men who have undergone androgen‑deprivation therapy (ADT)
Mechanism of Action Darolutamide selectively blocks androgen‑receptor (AR) signaling in prostate cancer cells, inhibiting tumor growth. It has low blood–brain barrier penetration, reducing central nervous system (CNS) side effects common to other AR inhibitors.
Key Clinical Evidence - PROSPER Trial (2019): 67% reduction in risk of metastasis and 52% reduction in mortality vs. placebo.
Dosage (US) 600 mg orally twice daily (or 400 mg BID in patients with moderate hepatic impairment).
Common Side Effects Fatigue, hypertension, dizziness, falls, nausea, diarrhea.
Contraindications Severe hepatic impairment; concurrent use of drugs that strongly inhibit or induce CYP3A4 (Darolutamide is metabolized by CYP3A4 but is not a major substrate).

About “Biosimilar” for Evenity

  • Darolutamide is a small‑molecule drug (a chemically synthesized organic compound), not a biologic (protein, peptide, or complex molecule produced by living cells).
  • Biosimilars are specifically designed for biologic products that are derived from living organisms. Because darolutamide is chemically manufactured, the regulatory framework for biosimilars does not apply.
  • Instead, you’ll find generic versions of darolutamide that are approved once the original patent expires. These generics are identical in active ingredient, strength, dosage form, and route of administration, but they are manufactured by other companies.

Generics (where available)

Region Approved Generic Name Manufacturer Status
United States Darolutamide (various, e.g., Pfizer, Generic manufacturers after patent expiration) Approved after 2028‑2030 (patent expiry TBD)
European Union Darolutamide (various) Approved post‑patent
India Darolutamide (generic producers) Approved

Note: As of now, no generic or “biosimilar” is on the market. When the first generic becomes available, it will be regulated under the generic drug pathway, ensuring equivalence in pharmacokinetics and efficacy.

Practical Tips for Patients & Providers

Situation Recommendation
Switching to a generic The FDA requires a “no‑interruption” policy for small‑molecule drugs. Switching is generally safe if the generic is bioequivalent.
Monitoring Check blood pressure regularly; watch for signs of fatigue or falls, especially in the elderly.
Drug interactions Avoid concurrent use of strong CYP3A4 inhibitors/inducers unless monitored; adjust dose accordingly.
Pregnancy & Lactation Not recommended; animal studies showed fetal toxicity.
Insurance Coverage Generic versions (once available) are typically less expensive and may be covered under many insurance plans.

Quick FAQ

Question Answer
Can I get a “biosimilar” Evenity? No. Darolutamide is a small‑molecule drug; biosimilars are for biologics only.
Will a generic be cheaper? Yes, generics are usually 20–80% cheaper than brand name, once approved.
Is it the same as enzalutamide or apalutamide? They are all AR inhibitors but differ in structure, CNS penetration, and side‑effect profiles. Darolutamide has lower CNS side effects.
What if I have liver disease? Dose adjustment may be required; consult your oncologist.

Bottom Line

Evenity (darolutamide) is a small‑molecule androgen‑receptor antagonist, not a biologic, so the concept of a “biosimilar” does not apply. You will see generic versions once the patent expires, which are pharmacologically identical to the brand product. If you’re considering a switch or have specific concerns (e.g., side effects, drug interactions, cost), talk with your oncology team—they can guide you based on your individual medical history.



Other Questions About Evenity :

when will evenity patent expire in canada?? Generic evenity? Evenity patent expiry date? Evenity biosimilar samsung? Is evenity a biologic drug? Evenity expiry date? Who makes evenity?